AlphaCentric Advisors’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

AlphaCentric Advisors’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,500	Closed	-$1.11M	–	253
2023 Q4	$1.11M	Buy	3,500 +2,750	+367%	+$535K	0.74%	51
2023 Q3	$127K	Buy	+750	New	+$141K	0.07%	176

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

AlphaCentric Advisors's KRTX Position: Q1 2024 in Review

AlphaCentric Advisors sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 3,500 shares — an estimated $1.11M sold.

AlphaCentric Advisors first reported a position in KRTX in Q3 2023 and held it in 2 quarters. The position peaked at $1.11M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

AlphaCentric Advisors reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
AlphaCentric Advisors sold 3,500 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.11M.
AlphaCentric Advisors first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
AlphaCentric Advisors's Karuna Therapeutics, Inc. Common Stock position peaked at $1.11M in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on AlphaCentric Advisors's 13F filing for Q1 2024, filed 24 Apr 2024.